Net Income (Loss) Attributable to Parent in USD of Coherus BioSciences, Inc. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Coherus BioSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q3 2025.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$35.5M, a 230% decline year-over-year.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $155M.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $28.5M.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$238M, a 18.5% increase from 2022.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$292M, a 1.62% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Coherus BioSciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $155M -$35.5M -$24.8M -230% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $180M $298M +$311M 01 Apr 2025 30 Jun 2025 10-Q 06 Nov 2025
Q1 2025 -$131M -$56.6M -$159M -155% 01 Jan 2025 31 Mar 2025 10-Q 06 Nov 2025
Q4 2024 $28.5M -$50.7M +$29M +36.4% 01 Oct 2024 31 Dec 2024 8-K 13 Nov 2025
Q3 2024 -$450K -$10.8M +$28.9M +72.9% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$29.3M -$12.9M +$29.9M +69.9% 01 Apr 2024 30 Jun 2024 10-Q 06 Nov 2025
Q1 2024 -$59.3M $103M +$179M 01 Jan 2024 31 Mar 2024 10-Q 06 Nov 2025
Q4 2023 -$238M -$79.7M -$20.8M -35.3% 01 Oct 2023 31 Dec 2023 8-K 13 Nov 2025
Q3 2023 -$217M -$39.6M +$47M +54.3% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$264M -$42.9M +$7.28M +14.5% 01 Apr 2023 30 Jun 2023 10-Q 06 Nov 2024
Q1 2023 -$271M -$75.7M +$20.4M +21.2% 01 Jan 2023 31 Mar 2023 10-Q 06 Nov 2024
Q4 2022 -$292M -$58.9M -$13.1M -28.7% 01 Oct 2022 31 Dec 2022 10-K 17 Mar 2025
Q3 2022 -$279M -$86.7M -$48.1M -125% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$230M -$50.2M -$20.3M -67.7% 01 Apr 2022 30 Jun 2022 10-Q 06 Nov 2023
Q1 2022 -$210M -$96.1M +$76.9M +44.4% 01 Jan 2022 31 Mar 2022 10-Q 06 Nov 2023
Q4 2021 -$287M -$45.7M -$55.4M -571% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2024
Q3 2021 -$232M -$38.5M -$66.5M -238% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$165M -$29.9M -$88.9M -151% 01 Apr 2021 30 Jun 2021 10-Q 08 Nov 2022
Q1 2021 -$76.3M -$173M -$209M -586% 01 Jan 2021 31 Mar 2021 10-Q 08 Nov 2022
Q4 2020 $132M $9.71M -$29.5M -75.3% 01 Oct 2020 31 Dec 2020 10-K 06 Mar 2023
Q3 2020 $162M $27.9M -$19.1M -40.6% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $181M $59M +$35.5M +150% 01 Apr 2020 30 Jun 2020 10-Q 08 Nov 2021
Q1 2020 $145M $35.6M +$55.6M 01 Jan 2020 31 Mar 2020 10-Q 08 Nov 2021
Q4 2019 $89.8M $39.2M +$102M 01 Oct 2019 31 Dec 2019 10-K 23 Feb 2022
Q3 2019 -$12M $47M +$106M 01 Jul 2019 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 -$118M $23.6M +$67.2M 01 Apr 2019 30 Jun 2019 10-Q 08 Nov 2019
Q1 2019 -$185M -$20M +$24.3M +54.8% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$209M -$62.6M -$13.5M -27.6% 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 -$196M -$58.8M +$181K +0.31% 01 Jul 2018 30 Sep 2018 10-K 27 Feb 2020
Q2 2018 -$196M -$43.6M +$11.7M +21.1% 01 Apr 2018 30 Jun 2018 10-K 27 Feb 2020
Q1 2018 -$208M -$44.3M +$30.5M +40.8% 01 Jan 2018 31 Mar 2018 10-K 27 Feb 2020
Q4 2017 -$238M -$49.1M +$26.9M +35.4% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 -$265M -$59M -$143M -170% 01 Jul 2017 30 Sep 2017 10-K 28 Feb 2019
Q2 2017 -$122M -$55.3M +$14.6M +20.9% 01 Apr 2017 30 Jun 2017 10-K 28 Feb 2019
Q1 2017 -$137M -$74.8M -$9.39M -14.4% 01 Jan 2017 31 Mar 2017 10-K 28 Feb 2019
Q4 2016 -$127M -$75.9M -$23.5M -44.9% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 -$104M $83.9M +$155M 01 Jul 2016 30 Sep 2016 10-K 08 Mar 2018
Q2 2016 -$259M -$70M -$11.2M -19% 01 Apr 2016 30 Jun 2016 10-K 08 Mar 2018
Q1 2016 -$248M -$65.4M -$24.7M -60.6% 01 Jan 2016 31 Mar 2016 10-K 08 Mar 2018
Q4 2015 -$223M -$52.4M -$23.3M -79.8% 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2017
Q3 2015 -$200M -$71.3M -$63.5M -806% 01 Jul 2015 30 Sep 2015 10-K 14 Mar 2017
Q2 2015 -$137M -$58.8M -$33.9M -136% 01 Apr 2015 30 Jun 2015 10-K 14 Mar 2017
Q1 2015 -$103M -$40.7M -$15.6M -61.8% 01 Jan 2015 31 Mar 2015 10-K 14 Mar 2017
Q4 2014 -$87.1M -$29.1M -$14.5M -99.7% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$72.6M -$7.87M +$13.6M +63.3% 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 -$86.2M -$25M -$16.2M -187% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$69.9M -$25.2M -$16.3M -184% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 -$53.6M -$14.6M 01 Oct 2013 31 Dec 2013 10-K 23 Mar 2015
Q3 2013 -$21.5M 01 Jul 2013 30 Sep 2013 10-K 23 Mar 2015
Q2 2013 -$8.71M 01 Apr 2013 30 Jun 2013 10-K 23 Mar 2015
Q1 2013 -$8.86M 01 Jan 2013 31 Mar 2013 10-K 23 Mar 2015

Coherus BioSciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $28.5M +$266M 01 Jan 2024 31 Dec 2024 8-K 13 Nov 2025
2023 -$238M +$53.9M +18.5% 01 Jan 2023 31 Dec 2023 8-K 13 Nov 2025
2022 -$292M -$4.65M -1.62% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025
2021 -$287M -$419M -317% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2024
2020 $132M +$42.4M +47.2% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 $89.8M +$299M 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 -$209M +$28.8M +12.1% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 -$238M -$111M -87% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 -$127M +$95.9M +43% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 -$223M -$136M -156% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 -$87.1M -$33.5M -62.5% 01 Jan 2014 31 Dec 2014 10-K 14 Mar 2017
2013 -$53.6M -$20.6M -62.4% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$33M 01 Jan 2012 31 Dec 2012 10-K 23 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.